M. Reddi

Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE)

J. Krell, E. Day, F. Fiorentino, 2022, Trials.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer : the prospective Streamline L trial

Steve Halligan, Vicky Goh, William Ricketts, 2019 .

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial

Steve Halligan, Vicky Goh, William Ricketts, 2019, The lancet. Gastroenterology & hepatology.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

A. Bhowmik, N. Strickland, V. Goh, 2019, The Lancet. Respiratory medicine.